Market Shares of IPCA, Cadila Health, makers of anti-coronavirus drug, surge in down market Updated : March 23, 2020 10:06 AM IST IPCA Labs rallied 17.7 percent to Rs 1,615.70 per share on BSE. Cadila Healthcare surged as much as 7.3 percent to Rs 307. As per CLSA, Hydroxychloroquine could be a huge near-term opportunity for Cadila. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.